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3 Lesion groups, the groups smoking or not, the SYNTAX score, collateral
circulation between grouping and hierarchical, the lever of CEACAM-1 pro-
tein, MMP-9 protein had no statistical difference.
4 In coronary heart disease (CHD) in serum did not detect the expression of
MMP-7.
Conclusions: the level of serum CEACAM-1 in patients with acute myocardial
infarction was clearly higher than normal coronary angiography, SAP group, UAP
group; This may suggest the level of CEACAM-1 associated with plaque instability
and thrombosis of regulating; Patients , who are Suffering from disease of Coronary
heart disease (CHD) with type 2 diabetes , their levels of serum CEACAM-1 was
clearly higher than other groups , this suggest the serum CEACAM-1 concentration
may be a reference factor as follow: coronary blood vessels in multivessel lesions
and diffuse lesion, and the increase in the incidence of cardiovascular disease.
CEACAM-1 might be of potential relevance as a clinically diagnostic tool and
therapeutic target.
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Objectives: To investigate the relationships between admission monocyte subsets and
early cardiovascular outcomes in patients with ST-elevation myocardial infarction
(STEMI) undergoing primary coronary interventions (PCI).
Methods: Flow cytometry (FCM) analysis of monocyte subsets was carried out upon
admission in 100 consecutive STEMI patients treated with PCI. Major adverse car-
diovascular events (MACE) were prospectively analyzed.
Results: Compared with stable CHD patients (n¼35), a reverse relationship between
monocyte count [increases in total monocyte counts, both determined by blood
routine test (RT) and FCM, as well as in CD14++CD16- monocytes; all P<0.001]
and lymphocyte count (decreased, P<0.001) was observed in STEMI patients.
During a 30-day follow-up, 7 STEMI patients experienced MACE. Kaplan-Meier
analysis demonstrated that an increased ratio of FCM-measured monocyte to
lymphocyte count (MTLR, P¼0.006) as well as an increased CD14++CD16– MTLR
(P¼0.006), but not CD14++CD16+ and CD14+CD16++ MTLRs, predicted MACE.
In multivariable analysis, FCM-measured MTLR (per 0.1 increase, HR: 1.451; 95%
CI: 1.018 to 2.068; P¼0.039) and CD14++CD16– MTLR (per 0.1 increase, HR:
1.533; 95% CI: 1.016 to 2.312; P¼0.042) independently predicted MACE. The
prognostic value was not observed in RT-measured monocyte count. Bland-Altman
plot and correlation analyses revealed a poor agreement between FCM- and RT-
measured monocyte count in STEMI patients (r¼0.578). In contrast, the correlation
of the monocyte count by these two methods was signiﬁcantly improved in stable
CHD patients (r¼0.861).
Conclusions: Acute STEMI-induced monocyte mobilization yields poor agreement
between RT- and FCM-measured admission monocyte counts. FCM-measured
admission MTLR and CD14++CD16– MTLR independently predict 30-day MACE in
STEMI patients treated with primary PCI.
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Objectives: To evaluate the effect of pre-treatment with statin on the reperfusion and
short-term clinical prognosis in patients with non ST-segment elevation acute
coronary syndrome (NSTE-ACS) who underwent successful primary percutanous
coronary intervention (PCI).
Methods: A total of 162 consecutive high –risk NSTE-ACS patients undergoing PCI
received simvastatin for 3 days before PCI. The patients were randomly divided into
two groups: standard statin group (20 mg simvastatin, n ¼ 81) and intensive statin
group (80 mg simvastatin, n ¼ 81). The difference of TIMI and myocardial blush
grade (MBG) of target arteries before and after PCI, serum leval of CK-MB at 24h,
LVEFand the incidence of main adverse cardiac events (MACE) at 30d follow-up
were examined in the 2 groups.
Results: The percentage of TIMI grade 2-3 ﬂow and MBG 2-3 perfusion were
signiﬁcantly higher in intensive statin group than that in standard statin group before
PCI (P< 0.05).The TIMI grade 3 ﬂow in intensive statin group showed similar result
to that in standard statin group after PCI, but the percentage of MBG 2-3 perfusion in
intensive statin group was signiﬁcantly higher than that in standard statin group
(P< 0.05).The incidence of increased CK-MB in intensive statin group was signiﬁ-
cantly lower than that in standard statin group ( P< 0.050.05).The LVEF in intensive
statin group was higher than that in standard statin group (P<0.05).It also showed
lower incidence of MACE (P<0.05) in intensive statin group than that in standard
statin group during 30 d after PCI.C134 JACC Vol 64/16/Suppl C j October 16–1Conclusions: Pre-treatment with high-dose statin for 3 days before PCI could improve
the coronary ﬂow, myocardial perfusion and heart function, attenuate the risk of
MACE during 30 d after PCI in high –risk NSTE-ACS patients.
GW25-e3538
Determinants and Prognosis of Spontaneous Coronary Reperfusion in ST-
segment Elevation Myocardial Infarction
Li Xiaoming, Boyu Li, Jing Li
Xuanwu hospital Capital Medical University, Beijing, China
Objectives: Angiographic spontaneous reperfusion (SR) was deﬁned as Thrombolysis
in Myocardial Infarction (TIMI) grade ﬂow 3 assessed by angiography before pri-
mary-PCI in the culprit vessel. However, determinants of SR and its impact on the
clinical outcomes are not clear.
Methods: Consecutive STEMI patients who received emergency coronary angi-
ography from January 2009 to August 2010 in our single center were included in
this study. All patients were divided into SR group (TIMI 3 grade) and non-SR
group (TIMI 0w2 grade) according to the results of the emergency coronary
angiography. Clinical and angiographic features were analyzed to explore the de-
terminants of SR. Long-term follow-up was analyzed between patients in SR group
and NSR group.
Results: Among 207 patients, a total of 38 (18.4%) patients met the criteria of SR.
The platelet (266.6466.91 x109/L vs 235.0467.59 x109/L, P¼0.012), blood level
of uric acid (298.0374.46mmol/L vs 334.2597.82mmol/L,P¼0.039) and glucose
(6.042.75 mmol/L vs 7.613.06 mmol/L, P¼0.005) levels were statistically
different between SR group and non-SR group. Multiple factors analysis showed
that the platelet (P¼0.010), blood glucose (OR¼0.750, 95% CI 0.622-0.903,
P¼0.003) and uric acid (OR¼0.993, 95% CI 0.987-0.998, P¼0.011) were inde-
pendent predictors for SR. The culprit lesions were more distal in SR group than
those in the non SR group (OR¼0.107, 95% CI 0.029-0.393, P¼0.001).Left anterior
descending branch recanalization occurred more often (OR¼0.285, 95% CI 0.105-
0.771, P¼0.013). MACCE in hospital was compared between the two groups. The
33 to 53-month’s follow-up showed that patients in SR group didn’t have a better
prognosis evaluated by Kaplan-Meier curves (P¼0.162). Younger people, lower
levels of blood glucose, uric acid and low density lipoprotein, were independent
predictors of a better outcome (P<0.05), which were evaluated by cox proportional
hazards regression.
Conclusions: SR is not uncommon in STEMI patients. Biochemical indexes and
lesion features are closely associated with SR. STEMI patients can beneﬁt from SR in
a short time, no more than about 3 years. STEMI patients may beneﬁt from controlling
the levels of blood glucose, uric acid and low density lipoprotein.
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Objectives: To study the relationship of abnormal expressed microRNA-21 of
CD4+T lymphocyte and myocardial injury after percutaneous coronary intervention in
patients with acute coronary sysdrome. To provide insights into the effects of
microRNA-21 on myocardial injury in patients undergoing PCI.
Methods: A total of 41 individuals with UA, who presented to the cardiology
department of the First Afﬁliated Hospital of Gannan Medical University were
enrolled from September 2011 to December 2011 The patients were divided into two
groups based on their troponin I (TnI) levels; elevated TnI group (TnI>0.15ng/ml, 20
cases) and normal TnI group (TnI0.15ng/ml, 21cases). Eighteen normal control
subjects who were conﬁrmed by coronary angiography were enrolled in the study. The
level of microRNA-21 expression was measured by qRT-PCR before PCI and 12h
after PCI. The level of IFN-gRa protein expression were examined using western
blotting and the level of serum IFN-g and IL-4 were detected by ELISA before PCI
and 12h after PCI. Correlation analysis was made between microRNA-21 and the
level of IFN-gRa protein, serum IFN-g and IL-4.
Results: Compared with the control group, the expression of microRNA-21 and IFN-
g were signiﬁcantly increased (all P<0.01), and the level of IFN-gRa was markly
decreased in the elevated TnI group and the normal TnI group before PCI (all
P<0.01). There was no signiﬁcant different in the level of IL-4 between the three
groups before PCI (P>0.05). There was no signiﬁcant different in the expression of
microRNA-21, IFN-gRa and IFN-g between the elevated TnI group and the normal
TnI group before PCI (all P>0.01). The expressions of microRNA-155, hsCRP, IFN-
g were signiﬁcant increased, and the level of IFN-gRa protein was decreased in the
elevated TnI group and the normal TnI group at 12h after PCI (all P<0.05). The
changes were more obvious in the elevated TnI group than the normal TnI group (all
P<0.05). There was no signiﬁcant different in the level of IL-4 in the elevated TnI
group and the normal TnI group before and after PCI in. The expressions of miRNA-
155 were signiﬁcantly positive with IFN-g (r¼0.649, P<0.01; r¼0.682, P<0.01
respectively), and signiﬁcantly negative with IFN-gRa before and after PCI
(r¼-0.536, P<0.01; r¼-0.592, P<0.01, respectively). There was no correlation be-
tween microRNA-21 and IL-4 before and after PCI (r¼-0.165, P¼0.303; r¼0.107,
P¼0.506, respectively).9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
